Key Record Dates
| ClinicalTrials.gov Identifier: | NCT04409262 |
|---|---|
| Brief Title: | A Study to Evaluate the Efficacy and Safety of Remdesivir Plus Tocilizumab Compared With Remdesivir Plus Placebo in Hospitalized Participants With Severe COVID-19 Pneumonia (REMDACTA) |
| First Submitted : | May 28, 2020 |
| First Submitted that Met QC Criteria : | May 28, 2020 |
| First Posted : | June 1, 2020 |
| Last Update Submitted that Met QC Criteria : | March 9, 2021 |
| Last Update Posted : | March 11, 2021 |